Hims & Hers Health, Inc. (HIMS) All Metrics
HIMS Valuation Metrics
HIMS Stock Price Metrics
HIMS Dividend Metrics
HIMS Growth Rate Metrics
HIMS Discounted Cash Flow Metrics
| Fair Value Price | $111.11 |
| Margin of Safety | 283.40% |
HIMS Revenue Metrics
HIMS PE Ratio Metrics
| PE Ratio | 56.45 |
| PE Ratio Avg TTM | 59.25 |
| PE Ratio Avg 3Y | 86.72 |
| Current VS TTM Avg | -4.72% |
| Current VS 3Y Avg | -34.91% |
| Current VS 5Y Avg | -34.91% |
HIMS PS Ratio Metrics
| PS Ratio | 2.79 |
| PS Ratio Avg TTM | 4.56 |
| PS Ratio Avg 3Y | 4.20 |
| Current VS TTM Avg | -38.88% |
| Current VS 3Y Avg | -33.62% |
| Current VS 5Y Avg | -36.34% |
HIMS PB Ratio Metrics
| PB Ratio | 14.83 |
| PB Ratio Avg TTM | 16.96 |
| PB Ratio Avg 3Y | 13.07 |
| Current VS TTM Avg | -12.56% |
| Current VS 3Y Avg | +13.43% |
| Current VS 5Y Avg | +54.87% |
HIMS Price to Free Cash Flow Ratio Metrics
| PFCF Ratio | 87.26 |
| PFCF Ratio Avg TTM | 77.36 |
| PFCF Ratio Avg 3Y | 70.86 |
| Current VS TTM Avg | +12.80% |
| Current VS 3Y Avg | +23.15% |
| Current VS 5Y Avg | +23.15% |
HIMS Debt to Equity Ratio Metrics
| Debt/Equity Ratio | 2.34 |
| Debt/Equity Ratio Avg TTM | 1.18 |
| Debt/Equity Ratio Avg 3Y | 0.60 |
| Current VS TTM Avg | +98.31% |
| Current VS 3Y Avg | +288.38% |
| Current VS 5Y Avg | +477.78% |
HIMS PEG Ratio Metrics
| PEG Ratio | 1.21 |
| PEG Ratio Avg TTM | 1.21 |
| PEG Ratio Avg 3Y | 1.21 |
| Current VS TTM Avg | 0.00% |
| Current VS 3Y Avg | 0.00% |
| Current VS 5Y Avg | 0.00% |
HIMS FCF Yield
| FCF Yield | 1.15% |
| FCF Yield Avg TTM | 1.43% |
| FCF Yield Avg 3Y | 1.61% |
| Current VS TTM Avg | -19.73% |
| Current VS 3Y Avg | -28.61% |
| Current VS 5Y Avg | -28.61% |
HIMS Earnings Yield
| Earnings Yield | 1.77% |
| Earnings Yield Avg TTM | 1.81% |
| Earnings Yield Avg 3Y | 1.52% |
| Current VS TTM Avg | -2.46% |
| Current VS 3Y Avg | +16.30% |
| Current VS 5Y Avg | +16.30% |
HIMS EV/EBIT Ratio Metrics
| Ev/Ebit Ratio | 240.91 |
| Ev/Ebit Ratio Avg TTM | 98.40 |
| Ev/Ebit Ratio Avg 3Y | 147.18 |
| Current VS TTM Avg | +144.82% |
| Current VS 3Y Avg | +63.68% |
| Current VS 5Y Avg | +63.68% |
HIMS EV/EBITDA Ratio Metrics
| Ev/Ebitda Ratio | 75.39 |
| Ev/Ebitda Ratio Avg TTM | 67.25 |
| Ev/Ebitda Ratio Avg 3Y | 332.85 |
| Current VS TTM Avg | +12.10% |
| Current VS 3Y Avg | -77.35% |
| Current VS 5Y Avg | -77.35% |
HIMS EV/Assets Ratio Metrics
| Ev/Assets Ratio | 3.32 |
| Ev/Assets Ratio Avg TTM | 6.03 |
| Ev/Assets Ratio Avg 3Y | 7.32 |
| Current VS TTM Avg | -44.98% |
| Current VS 3Y Avg | -54.65% |
| Current VS 5Y Avg | -42.55% |
HIMS EV/Sales Ratio Metrics
| Ev/Sales Ratio | 3.18 |
| Ev/Sales Ratio Avg TTM | 4.77 |
| Ev/Sales Ratio Avg 3Y | 4.20 |
| Current VS TTM Avg | -33.29% |
| Current VS 3Y Avg | -24.36% |
| Current VS 5Y Avg | -25.81% |
HIMS Current Ratio Metrics
| Current Ratio | 1.90 |
| Current Ratio Avg TTM | 1.84 |
| Current Ratio Avg 3Y | 2.80 |
| Current VS TTM Avg | +2.98% |
| Current VS 3Y Avg | -32.20% |
| Current VS 5Y Avg | -48.30% |
HIMS Quick Ratio Metrics
| Quick Ratio | 1.61 |
| Quick Ratio Avg TTM | 1.56 |
| Quick Ratio Avg 3Y | 2.48 |
| Current VS TTM Avg | +3.54% |
| Current VS 3Y Avg | -35.08% |
| Current VS 5Y Avg | -52.53% |
HIMS ROIC Metrics
| ROIC | 6.02% |
| ROIC Avg 3Y | (2.77%) |
| ROIC Avg 5Y | (9.72%) |
| Current VS 3Y Avg | -317.52% |
| Current VS 5Y Avg | -161.92% |
| Current VS 10Y Avg | -121.19% |
HIMS Return on Assets Metrics
| ROA | 5.96 |
| ROA Avg TTM | 11.88 |
| ROA Avg 3Y | 0.12 |
| Current VS TTM Avg | -49.85% |
| Current VS 3Y Avg | +4668.00% |
| Current VS 5Y Avg | -188.60% |
HIMS Return on Equity Metrics
| ROE | 23.73 |
| ROE Avg TTM | 25.09 |
| ROE Avg 3Y | 5.57 |
| Current VS TTM Avg | -5.40% |
| Current VS 3Y Avg | +326.42% |
| Current VS 5Y Avg | +5783.47% |
HIMS Net Profit Margin Metrics
| Net Profit Margin | 5.47% |
| Net Profit Margin Avg TTM | 7.00% |
| Net Profit Margin Avg 3Y | (0.29%) |
| Current VS TTM Avg | -21.91% |
| Current VS 3Y Avg | -2002.61% |
| Current VS 5Y Avg | -162.01% |
Last Updated: Tuesday, June 9, 2026
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Andrew Dudum